CVE-2026-60979
Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: Internal...
Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Scripting. Successful attacks of this vulnerability can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H).
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- High
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
CVE List Score used
8.1
Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Scripting. Successful attacks of this vulnerability can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H).
- Record
CVE-2026-60979- CVSS 3.1
- 8.1 High
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-306, CWE-284
- Updated
- 2026-11-02
EUVDEUVD-2026-47223
8.1
Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Scripting. Successful attacks of this vulnerability can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H).
- Record
EUVD-2026-47223- CVSS 3.1
- 8.1 High
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-pjcm-7mv5-f9w6
8.1
Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: Internal...
Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Scripting. Successful attacks of this vulnerability can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H).
- Record
GHSA-pjcm-7mv5-f9w6- CVSS 3.1
- 8.1 High
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-284
- Updated
- 2026-11-02
NVD
8.1
Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Difficult to exploit vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Scripting. Successful attacks of this vulnerability can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 8.1 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H).
- Record
CVE-2026-60979- CVSS 3.1
- 8.1 High
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-284, CWE-306
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2026-60979 is a high vulnerability (CVSS 8.1) in Oracle Scripting, published July 21, 2026. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.39%, the 33rd percentile. No source names a fixed version.